Report ID |
106728 |
Drug Identification Number |
02455609 |
Brand name |
CHOLESTYRAMINE-ODAN |
Common or Proper name |
Cholestyramine for Oral Suspension, USP |
Company Name |
ODAN LABORATORIES LTD |
Market Status |
MARKETED |
Active Ingredient(s) |
CHOLESTYRAMINE RESIN |
Strength(s) |
4G |
Dosage form(s) |
POWDER FOR SUSPENSION |
Route of administration |
ORAL |
Packaging size |
30 x 4g |
ATC code |
C10AC |
ATC description |
LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
|
Actual start date |
2020-02-19 |
Estimated end date |
2020-04-27 |
Actual end date |
2020-04-09 |
Shortage status |
Resolved |
Updated date |
2020-04-13 |
Company comments |
|
Health Canada comments |
|
Company contact information |
info@odanlab.com
Tel.: 1-800-387-9342
Fax: 1-800-329-6326 |